Skip to content
10-K

Annual Report

Dyne Therapeutics, Inc. DYN

0001193125-26-084178

← back to feed
Filed
Mar 2, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Capex FY 2025 · Dec 31, 2025 $1.92M
Capex FY 2025 · Dec 31, 2024 $2.38M
Capex FY 2025 · Dec 31, 2023 $729K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$403.21M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$292.37M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$188.16M
Cash And Equivalents FY 2025 · Dec 31, 2025 $893.37M
Cash And Equivalents FY 2025 · Dec 31, 2024 $435.45M
Stockholders Equity FY 2025 · Dec 31, 2025 $972.13M
Stockholders Equity FY 2025 · Dec 31, 2024 $629.84M
Stockholders Equity FY 2025 · Dec 31, 2023 $91.29M
Stockholders Equity FY 2025 · Dec 31, 2022 $252.36M
Current Liabilities FY 2025 · Dec 31, 2025 $50.63M
Current Liabilities FY 2025 · Dec 31, 2024 $42.26M
Total Liabilities FY 2025 · Dec 31, 2025 $214.83M
Total Liabilities FY 2025 · Dec 31, 2024 $61.4M
Current Assets FY 2025 · Dec 31, 2025 $1.13B
Current Assets FY 2025 · Dec 31, 2024 $659.28M
Total Assets FY 2025 · Dec 31, 2025 $1.19B
Total Assets FY 2025 · Dec 31, 2024 $691.23M
Eps Diluted FY 2025 · Dec 31, 2025 −$3.47
Eps Diluted FY 2025 · Dec 31, 2024 −$3.37
Eps Diluted FY 2025 · Dec 31, 2023 −$3.95
Eps Basic FY 2025 · Dec 31, 2025 −$3.47
Eps Basic FY 2025 · Dec 31, 2024 −$3.37
Eps Basic FY 2025 · Dec 31, 2023 −$3.95
Sga Expense FY 2025 · Dec 31, 2025 $69.85M
Sga Expense FY 2025 · Dec 31, 2024 $62.48M
Sga Expense FY 2025 · Dec 31, 2023 $31.4M
Rd Expense FY 2025 · Dec 31, 2025 $398.33M
Rd Expense FY 2025 · Dec 31, 2024 $281.41M
Rd Expense FY 2025 · Dec 31, 2023 $210.76M
Net Income FY 2025 · Dec 31, 2025 −$446.21M
Net Income FY 2025 · Dec 31, 2024 −$317.42M
Net Income FY 2025 · Dec 31, 2023 −$235.94M
Operating Income FY 2025 · Dec 31, 2025 −$468.18M
Operating Income FY 2025 · Dec 31, 2024 −$343.89M
Operating Income FY 2025 · Dec 31, 2023 −$242.16M